Predictmedix AI , a leader in artificial intelligence-driven health screening solutions, is expanding into the direct-to-consumer market with a mobile solution designed to deliver rapid, non-invasive diabetic screening — with India identified as the initial launchpad for this transformative initiative. Leveraging the company’s proprietary AI technology, the platform is intended to empower millions with instant access to diabetic risk assessments using only a smartphone, eliminating the need for blood draws, lab visits, or clinical infrastructure.

Health Technology Insights: Oceans Healthcare Names Dr. David Rubin Chief Medical Officer

Predictmedix AI is expanding into the direct-to-consumer market with a mobile solution designed to deliver rapid, non-invasive diabetic screening.

By combining advanced facial and biometric analysis with seamless smartphone delivery, the solution brings accessible, affordable, and scalable diabetic screening to some of the most underserved populations across India. This milestone represents a significant step in Predictmedix AI’s broader vision to reshape global healthcare delivery and accelerate the adoption of AI-enabled, mass-scale preventive health solutions.

“We are addressing a critical gap in healthcare access with a cutting-edge solution that empowers individuals to take control of their health using the device they already own — their mobile phone,” said Dr. Rahul Kushwah, COO of Predictmedix AI. “India has over 100 million diabetics and a significant number remain undiagnosed. Our app is designed to bridge that diagnostic divide.”

Health Technology Insights: Danaher appoints Greg Milosevich to Executive Vice President, Life Sciences

Key Features:

  • Instant Diabetic Risk Scoring via smartphone.
  • AI-driven facial and biometric analysis based on Predictmedix’s proven non-invasive screening platform.
  • User-friendly design with multilingual support for broad accessibility.
  • Secure, privacy-compliant data handling, in line with India’s Digital Personal Data Protection (DPDP) Act.

Strategic Significance:

India’s diabetes epidemic is accelerating, with estimates projecting nearly 1 in 3 adults to be diabetic or prediabetic by 2045. Simultaneously, smartphone adoption now exceeds 1.1 billion users — a convergence that creates a once-in-a-generation opportunity for mobile-first, AI-powered health solutions.

Our platform is uniquely positioned to:

  • Capture significant market share in a high-need, high-growth region.
  • Generate recurring revenue streams through direct-to-consumer and B2B channels.
  • Align with public health priorities of governments, NGOs, and large employers.
  • Scale globally with minimal marginal cost, leveraging cloud-based delivery.

Health Technology Insights: Colorado Access, Innovaccer Partner to Improve Medicaid Health

To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com

Source – businesswire